Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

pramipexole

pramipexole
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Mirapex ER TABLET, EXTENDED RELEASE, ORAL 0.375 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg    
Mirapex TABLET, ORAL 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg      
VIEW MORE Central Nervous System Agents, Miscellaneous
CLASS
289200
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

pramipexole (Mirapex ER)

  • 0.375 mg extended release oral tablet daily
  • 0.75 mg extended release oral tablet daily
  • 1.5 mg extended release oral tablet daily
  • 3 mg extended release oral tablet daily
  • 4.5 mg extended release oral tablet daily

pramipexole (Mirapex)

  • 0.125 mg tablet oral TID
  • 0.25 mg tablet oral TID
  • 0.5 mg tablet oral TID
  • 1 mg tablet oral TID
  • 1.5 mg tablet oral TID

Interchange Mirapex ER to regular release pramipexole tablets given TID, at the same total daily dosage.

Reviewed: May 25, 2010 (Mirapex ER)

Last updated: Dec. 26, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved